ALG3 predicts poor prognosis and increases resistance to anti-PD-1 therapy through modulating PD-L1 N-link glycosylation in TNBC
Bo Luo, Xiangdong Liu, Qu Zhang, Gai Liang, Ying Zhuang
Topics & Concepts
GlycosylationPD-L1Link (geometry)N-linked glycosylationCancer researchOncologyMedicineChemistryInternal medicineBiologyMolecular biologyGeneticsImmunotherapyComputer scienceCancerGlycoproteinGlycanComputer networkCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosisImmune cells in cancer